Compliance Policy Guide Sec. 510.800 Beverages-Serving Size Labeling; Compliance Policy Guide Sec. 540.420 Raw Breaded Shrimp-Microbiological Criteria for Evaluating Compliance With Current Good Manufacturing Practice Regulations; and Compliance Policy Guide Sec. 562.800 Vending Machine Food-Labeling; Withdrawal of Guidances, 8592-8593 [2022-03224]
Download as PDF
lotter on DSK11XQN23PROD with NOTICES1
8592
Federal Register / Vol. 87, No. 31 / Tuesday, February 15, 2022 / Notices
cause psychoactive effects and adverse
events, including deaths similar to
heroin, fentanyl, and other opioids. As
of January 2021, metonitazene has been
identified in eight blood specimens
associated with postmortem death
investigations in the United States.
There are no commercial or approved
medical uses for metonitazene. On
December 7, 2021, the DEA issued a
temporary order (86 FR 69182) to
control metonitazene as a Schedule I
substance under the CSA, therefore
additional permanent controls may be
needed if metonitazene is placed in
Schedule I of the 1961 Convention.
Eutylone (chemical name: 1-(1,3benzodioxol-5-yl)-2-(ethylamino)butan1-one) is a designer drug of the
phenethylamine class. Eutylone is a
synthetic cathinone with chemical
structural and pharmacological
similarities to Schedule I and II
amphetamines and cathinones, such as
to 3,4methylenedioxymethamphetamine,
methylone, and pentylone. Eutylone
emerged in the United States illicit,
synthetic drug market in 2014 as
evidenced by its identification in drug
seizures. Other evidence indicates that
eutylone, like other Schedule I synthetic
cathinones, is abused for its
psychoactive effects. Adverse effects
associated with synthetic cathinones
abuse include agitation, hypertension,
tachycardia, and death. Eutylone is not
approved for medical use in the United
States. As a positional isomer of
pentylone, eutylone is controlled in
Schedule I of the CSA. As such,
additional permanent controls will not
be needed if eutylone is placed in
Schedule II of the Convention on
Psychotropic Substances.
FDA, on behalf of the Secretary of
HHS, invites interested persons to
submit comments on the notifications
from the United Nations concerning
these drug substances. FDA, in
cooperation with the National Institute
on Drug Abuse, will consider the
comments on behalf of HHS in
evaluating the WHO scheduling
recommendations. Then, under section
201(d)(2)(B) of the CSA, HHS will
recommend to the Secretary of State
what position the United States should
take when voting on the
recommendations for control of
substances under the 1971 Convention
at the CND meeting in March 2022.
Comments regarding the WHO
recommendations for control of
brorphine and metonitazene under the
1961 Single Convention will also be
forwarded to the relevant Agencies for
consideration in developing the U.S.
VerDate Sep<11>2014
20:12 Feb 14, 2022
Jkt 256001
position regarding narcotic substances
at the CND meeting.
Dated: February 9, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022–03229 Filed 2–14–22; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA–2010–D–0575 and FDA–
2021–N–0764]
Compliance Policy Guide Sec. 510.800
Beverages—Serving Size Labeling;
Compliance Policy Guide Sec. 540.420
Raw Breaded Shrimp—Microbiological
Criteria for Evaluating Compliance
With Current Good Manufacturing
Practice Regulations; and Compliance
Policy Guide Sec. 562.800 Vending
Machine Food—Labeling; Withdrawal
of Guidances
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; withdrawal.
The Food and Drug
Administration (FDA or we) is
announcing the withdrawal of three
compliance policy guides (CPG) entitled
‘‘Compliance Policy Guide Sec. 510.800
Beverages—Serving Size Labeling,’’
‘‘Compliance Policy Guide Sec. 540.420
Raw Breaded Shrimp—Microbiological
Criteria for Evaluating Compliance with
Current Good Manufacturing Practice
Regulations,’’ and ‘‘Compliance Policy
Guide Sec. 562.800 Vending Machine
Food—Labeling.’’ We are withdrawing
these CPGs because they have become
outdated or have been superseded by
subsequent FDA actions.
DATES: The withdrawal is applicable
February 15, 2022.
ADDRESSES: For access to the docket, go
to https://www.regulations.gov and
insert docket number FDA–2010–D–
0575 for ‘‘Compliance Policy Guide Sec.
510.800 Beverages—Serving Size
Labeling’’ or FDA–2021–N–0764 for
‘‘Compliance Policy Guide Sec. 540.420
Raw Breaded Shrimp—Microbiological
Criteria for Evaluating Compliance with
Current Good Manufacturing Practice
Regulations’’ and ‘‘Compliance Policy
Guide Sec. 562.800 Vending Machine
Food—Labeling’’ into the ‘‘Search’’ box
and follow the prompts and/or go to the
Dockets Management Staff, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852,
240–402–7500.
FOR FURTHER INFORMATION CONTACT:
Kevin Kwon, Office of Compliance
SUMMARY:
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
(HFS–605), Center for Food Safety and
Applied Nutrition, Food and Drug
Administration, 5001 Campus Dr.,
College Park, MD 20740, 240–402–4597;
or Alexandra Jurewitz, Office of
Regulations and Policy (HFS–024),
Center for Food Safety and Applied
Nutrition, Food and Drug
Administration, 5001 Campus Dr.,
College Park, MD 20740, 240–402–2378.
SUPPLEMENTARY INFORMATION:
I. Background
We are announcing the withdrawal of
three CPGs entitled ‘‘Compliance Policy
Guide Sec. 510.800 Beverages—Serving
Size Labeling,’’ ‘‘Compliance Policy
Guide Sec. 540.420 Raw Breaded
Shrimp—Microbiological Criteria for
Evaluating Compliance with Current
Good Manufacturing Practice
Regulations,’’ and ‘‘Compliance Policy
Guide Sec. 562.800 Vending Machine
Food—Labeling.’’
CPG Sec. 510.800 entitled
‘‘Beverages—Serving Size Labeling’’ was
first issued in December 2010. This CPG
provided guidance for FDA staff and
industry as to when we would typically
consider not taking enforcement action
in connection to a ‘‘12 [fluid ounce]
(360 [milliliter])’’ labeled serving size on
specific types of beverages larger than
20 fluid ounces. On May 27, 2016, FDA
issued a final rule entitled ‘‘Food
Labeling: Serving Sizes of Foods That
Can Reasonably Be Consumed at One
Eating Occasion; Dual-Column Labeling;
Updating, Modifying, and Establishing
Certain Reference Amounts Customarily
Consumed; Serving Size for Breath
Mints; and Technical Amendments’’ (81
FR 34000). The final rule amended the
Reference Amounts Customarily
Consumed (RACCs) that are used by
manufacturers to determine serving
sizes for certain foods, including certain
beverages. Our regulations, at 21 CFR
101.12(b), table 2, lists the categories for
each type of food product and each
category’s current RACC. Due to the
updated RACCs for certain beverages,
CPG Sec. 510.800 is now obsolete, and
the enforcement discretion provided in
this CPG is no longer applicable.
Therefore, CPG Sec. 510.800 is being
withdrawn.
CPG Sec. 540.420 entitled ‘‘Raw
Breaded Shrimp—Microbiological
Criteria for Evaluating Compliance with
Current Good Manufacturing Practice
Regulations’’ was first issued in August
1983. This CPG used data collected in
fiscal year 1978 and listed an outdated
sampling and compliance structure. The
compliance criteria and the
methodology used in the CPG have
become outdated and are no longer
useful. This CPG is superseded by the
E:\FR\FM\15FEN1.SGM
15FEN1
Federal Register / Vol. 87, No. 31 / Tuesday, February 15, 2022 / Notices
Seafood Hazard Analysis Critical
Control Point regulation in 21 CFR part
123. Seafood processors must prevent
food safety hazards using critical
controls and appropriate verification
activities, such as end-product and inprocess testing (21 CFR part 123). This
CPG is also superseded by FDA’s Fish
and Fishery Products Hazards and
Controls Guidance (Ref. 1), which
describes controls for food safety
hazards related to breaded shrimp. For
these reasons, CPG Sec. 540.420 is now
obsolete and is being withdrawn.
CPG 562.800 entitled ‘‘Vending
Machine Food—Labeling’’ was first
issued in September 1976. This CPG
provided guidance for FDA staff and
industry regarding certain mandatory
label information for foods and
beverages dispensed in vending
machines after movement in interstate
commerce.
On March 23, 2010, President Obama
signed the Patient Protection and
Affordable Care Act of 2010 (ACA; Pub,
L, 111–148) into law. Section 4205 of
the ACA amended section 403(q) of the
Federal Food, Drug, and Cosmetic Act
(FD&C Act) (21 U.S.C. 343(q)) and
section 403A of the FD&C Act (21 U.S.C.
343–1), which governs Federal
preemption of State and local food
labeling requirements. Section 4205 of
the ACA added section 403(q)(5)(H)(viii)
to the FD&C Act to require that if an
article of food is sold from a vending
machine that (1) does not permit a
prospective purchaser to examine the
Nutrition Facts Panel before purchasing
the article or does not otherwise provide
visible nutrition information at the
point of purchase; and (2) is operated by
a person who is engaged in the business
of owning or operating 20 or more
vending machines, then the vending
machine operator must provide a sign in
close proximity to each article of food
or the selection button that includes a
clear and conspicuous statement
disclosing the number of calories
contained in the article of food.
In the Federal Register of December 1,
2014 (79 FR 71259), we issued a final
rule to implement these labeling
requirements; the regulations are
codified at 21 CFR 101.8. With this
regulatory change, CPG 562.800 is now
obsolete and is being withdrawn.
lotter on DSK11XQN23PROD with NOTICES1
II. Reference
The following reference is on display
at the Dockets Management Staff (see
ADDRESSES) and is available for viewing
by interested persons between 9 a.m.
and 4 p.m., Monday through Friday; it
is also available electronically at https://
www.regulations.gov.
VerDate Sep<11>2014
20:12 Feb 14, 2022
Jkt 256001
1. FDA, ‘‘Fish and Fishery Products Hazards
and Controls Guidance, 4th Edition,’’
June 2021.
Dated: February 9, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022–03224 Filed 2–14–22; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection: Public
Comment Request HRSA Ryan White
HIV/AIDS Program Part F AIDS
Education and Training Center
Program Evaluation Activities, OMB
No. 0915–0281—Extension
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In compliance with the
requirement for opportunity for public
comment on proposed data collection
projects of the Paperwork Reduction Act
of 1995, HRSA announces plans to
submit an Information Collection
Request (ICR), described below, to the
Office of Management and Budget
(OMB). Prior to submitting the ICR to
OMB, HRSA seeks comments from the
public regarding the burden estimate,
below, or any other aspect of the ICR.
DATES: Comments on this ICR should be
received no later than April 18, 2022.
ADDRESSES: Submit your comments to
paperwork@hrsa.gov or mail the HRSA
Information Collection Clearance
Officer, Room 14N136B, 5600 Fishers
Lane, Rockville, MD 20857.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and draft
instruments, email paperwork@hrsa.gov
or call Samantha Miller, the acting
HRSA Information Collection Clearance
Officer at (301) 443–9094.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the
information request collection title for
reference, pursuant to the Paperwork
Reduction Act of 1995.
Information Collection Request Title:
HRSA AIDS Education and Training
Center Evaluation Activities, OMB No.
0915–0281—Extension.
Abstract: The Ryan White HIV/AIDS
Program’s (RWHAP) AIDS Education
and Training Center (AETC) Program,
SUMMARY:
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
8593
authorized under Title XXVI of the
Public Health Service Act, supports a
network of regional and national centers
that conduct targeted, multi-disciplinary
education and training programs for
health care providers treating people
with HIV. The RWHAP AETC Program’s
purpose is to increase the number of
health care providers who are
effectively educated and motivated to
counsel, diagnose, treat, and medically
manage people with HIV.
The RWHAP AETC Program
recipients gather data on the training
activities they conduct using two data
collection instruments. The Event
Record (ER) gathers information about
each training activity including training
programs, individual clinical
consultations, group clinical
consultations, and technical assistance
events. Information on the people
trained, the length of training, the
content and level of the training and
collaborations with other organizations
is also collected. The Participant
Information Form (PIF) collects
information from each of the training
participants, including demographics,
profession, the types of HIV services
they provide, and the characteristics of
the patient population they serve. The
RWHAP AETC Program recipients are
required to report aggregated data on the
training activities and trainees to HRSA
once a year. HRSA is requesting an
extension of the current ER and PIF
with minor changes. To more accurately
capture the length of a training event,
RWHAP AETC trainers will be asked to
report the event’s end date in addition
to the start date on the ER. Additionally,
if an event was not supported by
RWHAP AETC core funding,
respondents will be able to skip three
subsequent questions on the ER that are
not applicable. Respondents will have
the option to report multiple clinic and
health professional program
identification numbers to reflect
multiple affiliations on the ER.
Additional options were added for
seven questions in the ER to allow for
more complete responses (e.g., an
‘‘other’’ response option was added to
two questions). In addition to changes
on the ER, minor revisions were made
to the response options for multiple
questions on the PIF to improve clarity
(e.g., ‘‘Substance Abuse’’ was changed
to ‘‘Substance Use Disorder’’).
Need and Proposed Use of the
Information: HRSA uses the data
collected when conducting RWHAP
AETC programmatic assessments to
determine future program needs. These
data allow HRSA to identify where gaps
exist in training HIV professionals as
well as to measure whether training
E:\FR\FM\15FEN1.SGM
15FEN1
Agencies
[Federal Register Volume 87, Number 31 (Tuesday, February 15, 2022)]
[Notices]
[Pages 8592-8593]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03224]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA-2010-D-0575 and FDA-2021-N-0764]
Compliance Policy Guide Sec. 510.800 Beverages--Serving Size
Labeling; Compliance Policy Guide Sec. 540.420 Raw Breaded Shrimp--
Microbiological Criteria for Evaluating Compliance With Current Good
Manufacturing Practice Regulations; and Compliance Policy Guide Sec.
562.800 Vending Machine Food--Labeling; Withdrawal of Guidances
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; withdrawal.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or we) is announcing the
withdrawal of three compliance policy guides (CPG) entitled
``Compliance Policy Guide Sec. 510.800 Beverages--Serving Size
Labeling,'' ``Compliance Policy Guide Sec. 540.420 Raw Breaded Shrimp--
Microbiological Criteria for Evaluating Compliance with Current Good
Manufacturing Practice Regulations,'' and ``Compliance Policy Guide
Sec. 562.800 Vending Machine Food--Labeling.'' We are withdrawing these
CPGs because they have become outdated or have been superseded by
subsequent FDA actions.
DATES: The withdrawal is applicable February 15, 2022.
ADDRESSES: For access to the docket, go to https://www.regulations.gov
and insert docket number FDA-2010-D-0575 for ``Compliance Policy Guide
Sec. 510.800 Beverages--Serving Size Labeling'' or FDA-2021-N-0764 for
``Compliance Policy Guide Sec. 540.420 Raw Breaded Shrimp--
Microbiological Criteria for Evaluating Compliance with Current Good
Manufacturing Practice Regulations'' and ``Compliance Policy Guide Sec.
562.800 Vending Machine Food--Labeling'' into the ``Search'' box and
follow the prompts and/or go to the Dockets Management Staff, 5630
Fishers Lane, Rm. 1061, Rockville, MD 20852, 240-402-7500.
FOR FURTHER INFORMATION CONTACT: Kevin Kwon, Office of Compliance (HFS-
605), Center for Food Safety and Applied Nutrition, Food and Drug
Administration, 5001 Campus Dr., College Park, MD 20740, 240-402-4597;
or Alexandra Jurewitz, Office of Regulations and Policy (HFS-024),
Center for Food Safety and Applied Nutrition, Food and Drug
Administration, 5001 Campus Dr., College Park, MD 20740, 240-402-2378.
SUPPLEMENTARY INFORMATION:
I. Background
We are announcing the withdrawal of three CPGs entitled
``Compliance Policy Guide Sec. 510.800 Beverages--Serving Size
Labeling,'' ``Compliance Policy Guide Sec. 540.420 Raw Breaded Shrimp--
Microbiological Criteria for Evaluating Compliance with Current Good
Manufacturing Practice Regulations,'' and ``Compliance Policy Guide
Sec. 562.800 Vending Machine Food--Labeling.''
CPG Sec. 510.800 entitled ``Beverages--Serving Size Labeling'' was
first issued in December 2010. This CPG provided guidance for FDA staff
and industry as to when we would typically consider not taking
enforcement action in connection to a ``12 [fluid ounce] (360
[milliliter])'' labeled serving size on specific types of beverages
larger than 20 fluid ounces. On May 27, 2016, FDA issued a final rule
entitled ``Food Labeling: Serving Sizes of Foods That Can Reasonably Be
Consumed at One Eating Occasion; Dual-Column Labeling; Updating,
Modifying, and Establishing Certain Reference Amounts Customarily
Consumed; Serving Size for Breath Mints; and Technical Amendments'' (81
FR 34000). The final rule amended the Reference Amounts Customarily
Consumed (RACCs) that are used by manufacturers to determine serving
sizes for certain foods, including certain beverages. Our regulations,
at 21 CFR 101.12(b), table 2, lists the categories for each type of
food product and each category's current RACC. Due to the updated RACCs
for certain beverages, CPG Sec. 510.800 is now obsolete, and the
enforcement discretion provided in this CPG is no longer applicable.
Therefore, CPG Sec. 510.800 is being withdrawn.
CPG Sec. 540.420 entitled ``Raw Breaded Shrimp--Microbiological
Criteria for Evaluating Compliance with Current Good Manufacturing
Practice Regulations'' was first issued in August 1983. This CPG used
data collected in fiscal year 1978 and listed an outdated sampling and
compliance structure. The compliance criteria and the methodology used
in the CPG have become outdated and are no longer useful. This CPG is
superseded by the
[[Page 8593]]
Seafood Hazard Analysis Critical Control Point regulation in 21 CFR
part 123. Seafood processors must prevent food safety hazards using
critical controls and appropriate verification activities, such as end-
product and in-process testing (21 CFR part 123). This CPG is also
superseded by FDA's Fish and Fishery Products Hazards and Controls
Guidance (Ref. 1), which describes controls for food safety hazards
related to breaded shrimp. For these reasons, CPG Sec. 540.420 is now
obsolete and is being withdrawn.
CPG 562.800 entitled ``Vending Machine Food--Labeling'' was first
issued in September 1976. This CPG provided guidance for FDA staff and
industry regarding certain mandatory label information for foods and
beverages dispensed in vending machines after movement in interstate
commerce.
On March 23, 2010, President Obama signed the Patient Protection
and Affordable Care Act of 2010 (ACA; Pub, L, 111-148) into law.
Section 4205 of the ACA amended section 403(q) of the Federal Food,
Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 343(q)) and section 403A
of the FD&C Act (21 U.S.C. 343-1), which governs Federal preemption of
State and local food labeling requirements. Section 4205 of the ACA
added section 403(q)(5)(H)(viii) to the FD&C Act to require that if an
article of food is sold from a vending machine that (1) does not permit
a prospective purchaser to examine the Nutrition Facts Panel before
purchasing the article or does not otherwise provide visible nutrition
information at the point of purchase; and (2) is operated by a person
who is engaged in the business of owning or operating 20 or more
vending machines, then the vending machine operator must provide a sign
in close proximity to each article of food or the selection button that
includes a clear and conspicuous statement disclosing the number of
calories contained in the article of food.
In the Federal Register of December 1, 2014 (79 FR 71259), we
issued a final rule to implement these labeling requirements; the
regulations are codified at 21 CFR 101.8. With this regulatory change,
CPG 562.800 is now obsolete and is being withdrawn.
II. Reference
The following reference is on display at the Dockets Management
Staff (see ADDRESSES) and is available for viewing by interested
persons between 9 a.m. and 4 p.m., Monday through Friday; it is also
available electronically at https://www.regulations.gov.
1. FDA, ``Fish and Fishery Products Hazards and Controls Guidance,
4th Edition,'' June 2021.
Dated: February 9, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022-03224 Filed 2-14-22; 8:45 am]
BILLING CODE 4164-01-P